Buprenorphine is a partial opioid receptor agonist. Its unique pharmacological properties help decrease the withdrawal effects of opioids. Buprenorphine is administered as a sublingual dissolvable, long-acting implantable, and long-acting injectable to treat opioid use disorder. The withdrawal symptoms of buprenorphine are milder than those of full agonist opioids. Visit Long Island Compassionate Medical Center, and we’ll explain the benefits of including buprenorphine in your treatment plan.
“I didn’t know I was lost till I found myself”
You are not alone. We understand that it takes determination to take the “first step”. You will feel some relief once you do. Learn more about some of the medications that Long Island Compassionate Medical Center uses to battle Opioid Use Disorder. The transformation of your life can start today.
The most widely known medication for treating opioid use disorder was approved by the FDA back in 2002. Since then, a generic version has been approved. The medication is a combination of two drugs—buprenorphine and naloxone that work together to decrease withdrawal symptoms and dependence on opioids.
Zubsolv and Suboxone contain similar ingredients (buprenorphine and naloxone) and are used for those who want to recover from opioid use disorder. One noticeable difference between the two is that Zubsolv has six available strengths, and Suboxone has four. Sometimes Zubsolv is preferred because of its minty-tasting tablet form. The tablet is typically placed under the tongue. Suboxone is administered via sublingual film, sometimes as a tablet on the inside of the cheek or under the tongue. Zubsolv dissolves quicker and is considered more bioavailable. Therefore, smaller doses can be taken for further individualized treatment plans that can lead to increased adherence.
If you are pregnant and trying to fight opioid addiction, fear not. We can help! We use an FDA-approved medication for pregnant women called Subutex. Subutex is the brand name for buprenorphine, which has been widely used and considered safe for women during pregnancy. We take the time to carefully evaluate and understand your lifestyle so we can provide an effective Medication-Assisted Treatment plan (MAT)
Sublocade is a monthly extended-release buprenorphine injection used to deliver a controlled rate of the medicine for moderate to severe opioid use disorder. Sublocade comes in dosage strengths of 100 mg and 300 mg.
Methadone is a long-acting opioid agonist which reduces opioid cravings and withdrawals. It blunts the sedative effects of opioids and protects a person from an opioid overdose. Methadone can be used only in Opioid Treatment Programs (OTPs) approved by the FDA to treat opioid use disorder. Only the oral formulation of methadone is administered to a patient. We do not currently prescribe methadone in our treatments plans however we feel it’s necessary to offer information in case you are a caregiver, friend, or family member that is trying to help a loved one.
Methadone is a long-acting opioid agonist which reduces opioid cravings and withdrawals. It blunts the sedative effects of opioids and protects a person from an opioid overdose. Methadone can be used only in Opioid Treatment Programs (OTPs) approved by the FDA to treat opioid use disorder. Only the oral formulation of methadone is administered to a patient. We do not currently prescribe methadone in our treatments plans however we feel it’s necessary to offer information in case you are a caregiver, friend, or family member that is trying to help a loved one.
It must be noted that we only accept insurance for Opioid Use Disorder Treatments. We do not accept insurance for your medical marijuana treatment plan.
Please note: Monday & Wednesday, the office is closed for patient consultations. Our patient support team is ONLY available by phone to answer questions or to help you make an appointment.